Werewolf Therapeutics, Inc. (NASDAQ: HOWL) reported Q4 EPS of ($0.46), $0.04 worse than the analyst estimate of ($0.42).

For earnings history and earnings-related data on Werewolf Therapeutics, Inc. (HOWL) click here.